Global Sepsis Diagnostics Market 2017-2021

敗血症診断の世界市場2017-2021:免疫測定検査、POCT、分子検査

◆タイトル:Global Sepsis Diagnostics Market 2017-2021
◆商品コード:IRTNTR14892
◆調査・発行会社:Technavio (Infiniti Research Ltd.)
◆発行日:2017年10月13日
◆ページ数:86
◆資料形式:PDF / 英語
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:医療・バイオ・製薬
◆販売価格オプション(消費税別)
Single User(1名利用)USD3,500 ⇒換算¥395,500見積依頼/購入/質問フォーム
Five User(~5名利用)USD4,000 ⇒換算¥452,000見積依頼/購入/質問フォーム
Enterprise License(全社内共有可)USD5,000 ⇒換算¥565,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、資料に記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はTechnavio (Infiniti Research Ltd.)の日本における正規販売代理店です。

【資料の概要】

Technavio社が発行した当調査レポートでは、敗血症診断の世界市場について調査・分析し、エグゼクティブサマリー、市場概観、市場概観、業界の構造分析、敗血症診断の世界市場規模及び予測、技術別分析、需要先別分析、地域別分析/市場規模、購買基準、市場の成長要因、市場の課題、市場動向、競争状況などの情報をお届けいたします。Technavio社は敗血症診断の世界市場が2017-2021年期間中に年平均6.74%成長すると予測しています。当レポート上に記載されている主な企業は、bioMérieux、T2 Biosystems等です。

・エグゼクティブサマリー
・敗血症診断の世界市場:市場概観
・敗血症診断の世界市場:業界の構造分析
・敗血症診断の世界市場:市場規模及び予測
・敗血症診断の世界市場:技術別分析
・敗血症診断の世界市場:需要先別分析
・敗血症診断の世界市場:地域別分析
・敗血症診断の世界市場:アジア市場規模
・敗血症診断の世界市場:アメリカ市場規模
・敗血症診断の世界市場:ヨーロッパ市場規模
・敗血症診断の世界市場:成長要因
・敗血症診断の世界市場:課題
・敗血症診断の世界市場:購買基準
・敗血症診断の世界市場:市場動向
・敗血症診断の世界市場:競争状況
...

※上記の和訳は最新内容ではない場合があります。下記の英文概要・目次が最新版です。

About Sepsis Diagnostics
Sepsis is a three-staged syndrome; it starts with systemic infections leading to severe sepsis and ultimately causing sepsis shock, which is regarded as a medical emergency. Population with weak immune system, which include children, older adults, and people with chronic diseases such as cancer, AIDS, diabetes, are prone to sepsis.
Sepsis occurs mainly due to bacterial, viral, and fungal infections. Gram-negative bacilli such as E. coli, P. aeruginosa, E. corrodens, and Haemophilus influenzae (which occurs mainly in neonates) are the main agents that cause infection, leading to sepsis. Other bacteria which causes sepsis are S. aureus, Streptococcus species, Enterococcus species, and Neisseria species.

Technavio’s analysts forecast the global sepsis diagnostics market to grow at a CAGR of 6.74% during the period 2017-2021.

[Covered in this report]
The report covers the present scenario and the growth prospects of the global sepsis diagnostics market for 2017-2021. To calculate the market size, the report considers the sales, volume and value of global sepsis diagnostics segment.

The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA

Technavio’s report, Global Sepsis Diagnostics Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

[Key vendors]
• bioMérieux
• T2 Biosystems

[Other prominent vendors]
• Alere
• Abionic
• AdvanDx
• Aethlon Medical
• AusDiagnostics
• Beckman Coulter
• Beckton Dickinson
• Momentum Bioscience
• Bio-Rad Laboratories
• Bruker
• Cepheid
• Curetis
• CytoSorbents
• Fast Track Diagnostics
• F. Hoffmann-La Roche
• Fujirebio Europe
• Hansa Medical
• Hain Lifescience
• Immunexpress
• Inflammatix
• Merck
• miacom diagnostics
• Mitsubishi Chemical Europe
• Nanōmix
• QIAGEN
• Radiometer
• Response Biomedical
• Sepset Biosciences
• Siemens Healthineers
• TCS Biosciences
• Thermo Fisher Scientific

[Market driver]
• Rising prevalence of hospital acquired infection (HAIs) globally
• For a full, detailed list, view our report

[Market challenge]
• High cost of sepsis treatment
• For a full, detailed list, view our report

[Market trend]
• Increasing use of biomarkers for sepsis
• For a full, detailed list, view our report

[Key questions answered in this report]
• What will the market size be in 2021 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?

*** You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.

【資料の目次】

Table of Contents
PART 01: Executive summary

PART 02: Scope of the report

PART 03: Research methodology

PART 04: Introduction
• Market outline

PART 05: Market landscape
• Market overview
• Market size and forecast
• Five forces analysis

PART 06: Market segmentation by technology
• Market overview
• Immunoassay testing
• POCT
• Molecular testing

PART 07: Market segmentation by end-user
• Market overview
• Hospital and clinics
• Diagnostic laboratories

PART 08: Geographical segmentation
• Sepsis diagnostics market in Americas
• Sepsis diagnostics market in EMEA
• Sepsis diagnostics market in APAC

PART 09: Decision framework

PART 10: Drivers and challenges
• Market drivers
• Market challenges

PART 11: Market trends
• Development of novel products
• Increasing use of biomarkers for sepsis
• Increasing online campaigns for sepsis awareness

PART 12: Vendor landscape
• Competitive landscape

PART 13: Key vendors
• bioMérieux
• T2 Biosystems
• Key companies to watch
• Other prominent vendors
• List of abbreviations

PART 14: Appendix

[List of Exhibits]
Exhibit 01: Stages of sepsis
Exhibit 02: Products offered for severity of sepsis
Exhibit 03: Market overview: Global sepsis diagnostics market 2016-2021
Exhibit 04: Global sepsis diagnostics market 2016-2021 ($ millions)
Exhibit 05: Reimbursement for sepsis in the US
Exhibit 06: Five forces analysis
Exhibit 07: Market overview of sepsis diagnostics by technology 2016
Exhibit 08: Global sepsis diagnostics market by immunoassay testing 2016-2021 ($ millions)
Exhibit 09: Global sepsis diagnostics market by POCT 2016-2021 ($ millions)
Exhibit 10: Global sepsis diagnostics market by molecular testing 2016-2021 ($ millions)
Exhibit 11: Strategic analysis: Global sepsis diagnostics market by end-users 2016
Exhibit 12: Buying criteria for global sepsis diagnostics market by end user 2016
Exhibit 13: Global sepsis diagnostics market by geography in 2016 and 2021 ($ millions)
Exhibit 14: Market overview: Sepsis diagnostics market in Americas 2016-2021
Exhibit 15: Sepsis diagnostics market in Americas 2016-2021 ($ millions)
Exhibit 16: Market overview: Sepsis diagnostics market in EMEA 2016-2021
Exhibit 17: Sepsis diagnostics market in EMEA 2016-2021 ($ millions)
Exhibit 18: Market overview: Sepsis diagnostics market in APAC 2016-2021
Exhibit 19: Sepsis diagnostics market in APAC 2016-2021 ($ millions)
Exhibit 20: Market analysis: Sepsis-related to HAI
Exhibit 21: Ongoing clinical trials by NHS in the UK
Exhibit 22: Competitive structure analysis of global sepsis diagnostics market 2016
Exhibit 23: Market penetration of various global sepsis diagnostics market providers 2016
Exhibit 24: Strategic success factors of companies in global sepsis diagnostics market 2016
Exhibit 25: bioMérieux: Key highlights
Exhibit 26: bioMérieux: Strength assessment
Exhibit 27: bioMérieux: Strategy assessment
Exhibit 28: bioMérieux: Opportunity assessment
Exhibit 29: T2 Biosystems: Key highlights
Exhibit 30: T2 Biosystems: Strength assessment
Exhibit 31: T2 Biosystems: Strategy assessment
Exhibit 32: T2 Biosystems: Opportunity assessment
Exhibit 33: Abbott: Company assessment
Exhibit 34: Nanosphere: Company assessment



【掲載企業】

bioMérieux, T2 Biosystems, Alere, Abionic, AdvanDx, Aethlon Medical, AusDiagnostics, Beckman Coulter, Beckton Dickinson, Momentum Bioscience, Bio-Rad Laboratories, Bruker, Cepheid, Curetis, CytoSorbents, Fast Track Diagnostics, F. Hoffmann-La Roche, Fujirebio Europe, Hansa Medical, Hain Lifescience, Immunexpress, Inflammatix, Merck, miacom diagnostics, Mitsubishi Chemical Europe, Nanōmix, QIAGEN, Radiometer, Response Biomedical, Sepset Biosciences, Siemens Healthineers, TCS Biosciences, and Thermo Fisher Scientific.


【免責事項】
※当資料上の情報/データは調査会社が信頼できると判断した情報源から入手したものに基づき作成しましたが、その正確性・完全性を保証するものではありません。当資料に記載された情報/データ/見解/仮説などは作成時点又は発行時点における調査会社の判断であり、その後の状況変化に応じて変更される場合があります。当資料上の情報/データに基づいたお客様の意思決定又は実行による結果について、調査会社/発行会社/販売会社H&Iグローバルリサーチはその責を負いかねますのでご了承ください。英文資料の紹介ページにおける日本語題名/概要/目次はH&Iグローバルリサーチが翻訳した内容であり、翻訳の正確性・完全性を保証するものではありません。

[敗血症診断の世界市場2017-2021:免疫測定検査、POCT、分子検査]についてメールでお問い合わせはこちら


◆H&Iグローバルリサーチ株式会社のお客様(例)◆